SynthesisFrontiers in immunology2026

Oral mucositis risk with EGFR tyrosine kinase inhibitor monotherapies and combination regimens in non-small cell lung cancer: a systematic review and network meta-analysis.

Huiwen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.